Bailey Gleason Fitzgerald
@BaileyFitz
Followers
171
Following
622
Media
1
Statuses
39
RT @SinaiHemeOnc: We are delighted to present our newest class of incoming hematology and oncology fellows @TischCancer @MountSinaiNYC! In….
0
6
0
RT @EGFRSummit: Day ☝️ going strong with our alumni & Young Investigators getting to know our Judge Mentors better. Making connections and….
0
10
0
RT @YaleCancer: Tonight at 7:30pm on Yale Cancer Answers, join us to learn about the field of classical #hematology and current research in….
0
5
0
RT @TalalZarif1: 🚨On behalf of my amazing co-authors, I'm super excited to share our findings on safety/efficacy of #ICI for #NSCLC among p….
0
16
0
RT @SinaiHemeOnc: End-of-summer fellows & faculty picnic in Central Park replete with food, games, sun and camaraderie! .👏🏼 to our wellness….
0
3
0
RT @JuliaFoldiMD: What a great workshop, thank you @SocTransOnc! Great to meet so many amazing young oncologists, learn from leaders in tra….
0
1
0
RT @DDoroshow: @DevikaDasMD @StephenVLiu @BaileyFitz and I are opening a study at @MSHSThoracicOnc of 1L pembro for pts with PS 2-3 with pr….
0
1
0
RT @TischCancer: .@BaileyFitz presented today at @ASCO22: .A phase 1b/2 trial of dupilumab given in conjunction with PD-(L)1 blockade in th….
0
2
0
RT @IcahnMountSinai: Today at @ASCO, Drs. Melanie Wain Kier, @EdgarEGK, @RimapatelMD, and @BaileyFitz, shared their latest oncology researc….
0
1
0
I’m extremely lucky to be at @SinaiHemeOnc where I get to work with her, as well as amazing mentors like Tom Marron, @ChristianRolfo , @NickRohsMD, Raj Veluswamy, @fred_hirsch to expand this project into a large systemic analysis to identify risk factors for 1L osi resistance.
0
0
6
Could not ask for a better mentor for this project (and so much else) than senior author @DDoroshow!.
#TTLC22 Dr. @BaileyFitz presents P29 describing 7 pts with #EGFR mutant NSCLC who had progression within 6m of starting 1L osimertinib. High rates of TP53 alterations and also noted EGFR, BRAF, KRAS amplification. #LCSM
1
1
8
RT @GeorgeGoshuaMD: 1/ @AjHematology during @RareDiseases month. Rituximab-splenectomy-TPO or splenectomy-rituximab-TPO is cost-effective i….
0
8
0
RT @SinaiHemeOnc: Warmest of welcomes to our new first year fellows! Looking forward to working and learning with you all as we start anoth….
0
1
0
RT @SinaiHemeOnc: We can't contain our excitement for our fellowship APD @DDoroshow being awarded the prestigious @ASCO #ConquerCancer Care….
0
3
0
RT @uche_blackstock: Even brighter news! . Dr. Marcella Nunez-Smith, associate professor and founding director of the Equity Research and I….
nhregister.com
Marcella Nunez-Smith will be one of three co-chairs of the group, two sources reportedly...
0
431
0
0
1
0
RT @YihanYangMD: Wonderful @YaleIMed grand rounds on use of social media by physicians. Great job Leilah! @YaleIM_Chiefs .
0
2
0
RT @davidrosenthal: Social media for physicians: benefits, challenges, and opportunities ahead by Leila Haghighat @YaleIM_Chiefs #yalemgr #….
0
2
0
RT @YaleIM_Chiefs: PGY-3 @KayleShapero taking us through the decade's Top 10 advancements in #cardiology: #CAC scores, #SGLT2 inhibitors, h….
0
3
0
RT @GeorgeGoshuamd: Rare Disease Day 2019 is coming! Yale Medical Grand Rounds Feb 14 8.30 AM on Rare Disease. #ShowYourRare .
0
2
0